Please Wait.....
Report
Global IV & Oral Iron Drugs Market - Focused Insights 2024-2029
Market Report I 2024-02-06 I 126 Pages I Arizton Advisory & Intelligence
The global IV and Oral Iron Drugs market, valued at $7.66 billion in 2023, will experience robust growth by 2029, expanding at a CAGR of 13.47%. This surge is primarily driven by the increasing prevalence of Iron Deficiency (ID) and Iron Deficiency Anemia (IDA) globally, coupled with a heightened awareness among patients about effective treatment options. The market's expansion is further propelled by the rising occurrence of chronic diseases such as Chronic Kidney Disease (CKD), heart failure, gastrointestinal disorders, and cancer, which can lead to iron deficiency, particularly in surgical patients.
Key factors fueling market growth include the growing demand for dextran-free iron therapeutics and the rising need for iron drugs among dialysis and non-dialysis kidney patients. The market also benefits from the development of investigational latest generation IV & oral iron drugs with broader indications and improved treatment outcomes.
Market leaders like Vifor Pharma are significantly contributing with products such as Ferinject (marketed as Injectafer in the US) and Venofer, which are gaining traction, especially among dialysis patients. The oral iron drug segment, comprising both prescription and OTC preparations, is expanding steadily, although slower than IV iron drugs, with significant growth in emerging and low-income countries due to their cost-effectiveness.
The market's growth is not just confined to developed nations; it's also significant in developing countries across Asia, Africa, and Latin America, where iron deficiency poses a severe health challenge. This growth is further augmented by innovations in hospital pharmacy practice and retail store involvement, facilitating accessibility and awareness among consumers.
The hospital pharmacies segment is expected to grow due to their specialized services in iron medicines. At the same time, retail stores continue to play a crucial role due to immediate product availability and expert guidance. The prevalence of iron deficiency in CKD patients, which is estimated to be around 70%, highlights the critical need for iron therapy with IV and oral iron drugs.
As the global IV & oral iron drugs market evolves, key vendors like Vifor Pharma, Daiichi Sankyo Group, AMAG Pharmaceuticals, and others focus on product innovations and expanded label approvals to meet the growing demands and adapt to new patient groups. The market, characterized by the presence of global, regional, and local players, is highly competitive with a wide array of branded and generic drug offerings.
KEY HIGHLIGHTS:
- The IV & oral iron drugs market represents a rapidly growing and most effective category of therapeutics that helps individuals with ID & IDA to improve their quality of life.
- By route of administration, the intravenous (IV) segment was valued at $4.40 billion in 2023. This growth mainly results from the expected launch of branded IV iron drugs in new markets and expanded indication approval for existing commercially available brands. One of the primary reasons for this significant growth rate is the increased uptake of branded IV drugs in the US and European markets.
- By patient group, the adult segment is going to witness notable growth during the forecast period. In 2023, the adult segment accounted for 83.33% of the global IV & oral iron drugs market. The segment is dominating the market due to the higher incidence/ prevalence of ID and IDA among elderly people across the world.
- By distribution channel, the hospital pharmacies segment is expected to grow at a significant CAGR. Hospital pharmacies offer iron drugs with adequate discounts and rebates. Thus offering a cost-effective way to minimize the burden on patients and healthcare systems.
- By application, In 2023, the nephrology segment accounted for 60.84% of the global IV & oral iron drugs market. The market for iron drugs in nephrology is increasing faster, and the trend is likely to continue during the forecast period due to the rising prevalence of CKD worldwide. The segment accounted for the largest market share owing to the increasing uptake of iron drugs to treat CKD.
- CSL Vifor, Covis Pharmaceuticals, Daiichi Sankyo, Akebia Therapeutics, Shield Therapeutics, and others are some of the leading players currently dominating the global IV & Oral iron drugs market. The major players focus on strategic acquisitions and collaborations with emerging players to enter the IV & Oral Iron Drugs market and to gain access to commercially launched products.
REPORT HIGHLIGHTS
PRODUCT SEGMENTATION & FORECAST
- Route of Administration
- Intravenous
- Oral
- Patient Group
- Adults
- Pediatrics
- Distribution Channel
- Hospital Pharmacies
- Offline Retail Pharmacies
- Online Channels
- Application
- Nephrology
- Obstetrics & Gynaecology
- Surgery
- Gastroenterology
- Oncology
- Heart Failure
- MARKET STRUCTURE
- Market Dynamics
- Competitive Landscape of IV & Oral Iron Drugs Market
- Key Vendors
- Other Prominent Vendors
- APPENDIX
- Research Methodology
- Abbreviations
- About Arizton
VENDORS LIST
- CSL Vifor
- Daiichi Sankyo
- Covis Pharmaceuticals
- Akebia Therapeutics
- Shield Therapeutics
- Pharmacosmos
- AbbVie
- Sanofi
- AOP Orphan Pharmaceuticals
- Azad Pharmaceuticals
- Pfizer
- Ciron Drugs & Pharmaceuticals
- Rockwell Medical
- Salveo Lifecare
- Sunny Pharmaceuticals
- Zydus LifeSciences
- Nippon Shinyaku
- Alinter Group
- Alora Pharmaceuticals
- DSE Healthcare
- GSK plc
CHAPTER - 1: IV & Oral Iron Drugs Market Overview
- Executive Summary
- Key Findings
CHAPTER - 2: IV & Oral Iron Drugs Market
- GLOBAL: Projected Revenue of IV & Oral Iron Drugs Market (2023-2029; $Billions)
CHAPTER - 3: IV & Oral Iron Drugs Market Segmentation Data
- GLOBAL: Projected Revenue by Route of Administration (2023-2029; $Billions)
- Intravenous
- Oral
- GLOBAL: Projected Revenue by Patient Group (2023-2029; $Billions)
- Adults
- Pediatrics
- GLOBAL: Projected Revenue by Distribution Channel (2023-2029; $Billions)
- Hospital Pharmacies
- Offline Retail Pharmacies
- Online Channels
- GLOBAL: Projected Revenue by Application (2023-2029; $Billions)
- Nephrology
- Obstetrics & Gynecology
- Surgery
- Gastroenterology
- Oncology
- Heart Failure
CHAPTER - 4: Key Regions Overview
- North America: Projected Revenue of IV & Oral Iron Drugs Market (2023-2029; $Billions)
- Projected Revenue of IV & Oral Iron Drugs Market in US
- Projected Revenue of IV & Oral Iron Drugs Market in Canada
- Europe: Projected Revenue of IV & Oral Iron Drugs Market (2023-2029; $Billions)
- Projected Revenue of IV & Oral Iron Drugs Market in Germany
- Projected Revenue of IV & Oral Iron Drugs Market in UK
- Projected Revenue of IV & Oral Iron Drugs Market in France
- Projected Revenue of IV & Oral Iron Drugs Market in Italy
- Projected Revenue of IV & Oral Iron Drugs Market in Spain
- APAC: Projected Revenue of IV & Oral Iron Drugs Market (2023-2029; $Billions)
- Projected Revenue of IV & Oral Iron Drugs Market in Japan
- Projected Revenue of IV & Oral Iron Drugs Market in China
- Projected Revenue of IV & Oral Iron Drugs Market in Australia
- Latin America: Projected Revenue of IV & Oral Iron Drugs Market (2023-2029; $Billions)
- Projected Revenue of IV & Oral Iron Drugs Market in Brazil
- Projected Revenue of IV & Oral Iron Drugs Market in Mexico
- Projected Revenue of IV & Oral Iron Drugs Market in Argentina
- Middle East & Africa: Projected Revenue of IV & Oral Iron Drugs Market (2023-2029; $Billions)
- Projected Revenue of IV & Oral Iron Drugs Market in Turkey
- Projected Revenue of IV & Oral Iron Drugs Market in South Africa
- Projected Revenue of IV & Oral Iron Drugs Market in Saudi Arabia
CHAPTER - 5: IV & Oral Iron Drugs Market Prospects & Opportunities
- IV & Oral Iron Drugs Market Opportunities & Trends
- IV & Oral Iron Drugs Market Drivers
- IV & Oral Iron Drugs Market Constraints
CHAPTER - 6: IV & Oral Iron Drugs Industry Overview
- IV & Oral Iron Drugs Market - Competitive Landscape
- IV & Oral Iron Drugs Market - Key Vendor Profiles
- IV & Oral Iron Drugs Market - Other Prominent Vendors
- IV & Oral Iron Drugs Market - Key Strategic Recommendations
CHAPTER - 7: Appendix
- Research Methodology
- Abbreviations
- About Arizton
LIST OF EXHIBITS
Exhibit 1: Projected Revenues of IV & Oral Iron Drugs in Global ($ Bn)
Exhibit 2: Market Size & Forecast - Intravenous ($ Bn)
Exhibit 3: Market Size & Forecast - Oral ($ Bn)
Exhibit 4: Market Size & Forecast - Adults ($ Bn)
Exhibit 5: Market Size & Forecast - Pediatrics ($ Bn)
Exhibit 6: Market Size & Forecast - Hospital Pharmacies ($ Bn)
Exhibit 7: Market Size & Forecast - Offline Retail Stores
Exhibit 8: Market Size & Forecast - Online Channels ($ Bn)
Exhibit 9: Market Size & Forecast - Nephrology ($ Bn)
Exhibit 10: Market Size & Forecast - Obstetrics & Gynecology ($ Bn)
Exhibit 11: Market Size & Forecast - Surgery ($ Bn)
Exhibit 12: Market Size & Forecast - Gastroenterology ($ Bn)
Exhibit 13: Market Size & Forecast - Oncology ($ Bn)
Exhibit 14: Market Size & Forecast - Heart Failure ($ Bn)
Exhibit 17: Projected Revenues of IV & Oral Iron Drugs in North America ($ Bn)
Exhibit 18: Projected Revenues of IV & Oral Iron Drugs in US ($ Bn)
Exhibit 19: Projected Revenues of IV & Oral Iron Drugs in Canada ($ Bn)
Exhibit 20: Projected Revenues of IV & Oral Iron Drugs in Europe ($ Bn)
Exhibit 21: Projected Revenues of IV & Oral Iron Drugs in Germany ($ Bn)
Exhibit 22: Projected Revenues of IV & Oral Iron Drugs in UK ($ Bn)
Exhibit 23: Projected Revenues of IV & Oral Iron Drugs in France ($ Bn)
Exhibit 24: Projected Revenues of IV & Oral Iron Drugs in Italy ($ Bn)
Exhibit 25: Projected Revenues of IV & Oral Iron Drugs in Spain ($ Bn)
Exhibit 26: Projected Revenues of IV & Oral Iron Drugs in APAC ($ Bn)
Exhibit 27: Projected Revenues of IV & Oral Iron Drugs in Japan ($ Bn)
Exhibit 28: Projected Revenues of IV & Oral Iron Drugs in China ($ Bn)
Exhibit 29: Projected Revenues of IV & Oral Iron Drugs in Australia ($ Bn)
Exhibit 30: Projected Revenues of IV & Oral Iron Drugs in Latin America ($ Bn)
Exhibit 31: Projected Revenues of IV & Oral Iron Drugs in Brazil ($ Bn)
Exhibit 32: Projected Revenues of IV & Oral Iron Drugs in Mexico ($ Bn)
Exhibit 33: Projected Revenues of IV & Oral Iron Drugs in Argentina ($ Bn)
Exhibit 34: Projected Revenues of IV & Oral Iron Drugs in Middle East & Africa ($ Bn)
Exhibit 35: Projected Revenues of IV & Oral Iron Drugs in Turkey ($ Bn)
Exhibit 36: Projected Revenues of IV & Oral Iron Drugs in South Africa ($ Bn)
Exhibit 37: Projected Revenues of IV & Oral Iron Drugs in Saudi Arabia ($ Bn)
LIST OF TABLES
Table 1: Key Market Trends in IV & Oral Iron Drugs Market
Table 2: Key Market Enablers in IV & Oral Iron Drugs Market
Table 3: Key Market Constraints in IV & Oral Iron Drugs Market
Table 4: Strategic Recommendations in IV & Oral Iron Drugs Market
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security